GLP-1s for T2D: real talk

GLP-1 MEDICATIONS FOR TYPE 2 DIABETES: WHAT YOU NEED TO KNOW

Hi everyone. I have been around this space for a while and I keep seeing the same questions pop up: insurance denials, confusion about dosing, whether newer agents are "better," how to handle rising A1C after early success, and how much of this is the shot versus lifestyle.

This post is meant to be a practical, experience-based overview focused on diabetes management. Not hype. Not shortcuts. Just what we know so far from real-world users and published data.

If you are newly diagnosed, frustrated with coverage, or wondering what comes after initial success, read on.

--------------------------------------------------
1. QUICK OVERVIEW: WHAT ARE THESE MEDS?
--------------------------------------------------

The medications most people here talk about fall into three broad categories:

  • GLP-1 receptor agonists (e.g., semaglutide-type medications)
  • Dual incretin agonists (GLP-1 + GIP, e.g., tirzepatide-type medications)
  • Triple agonists (GLP-1 + GIP + glucagon receptor activity, e.g., retatrutide-type agents still under investigation)

For type 2 diabetes (T2D), these drugs primarily:

  • Increase glucose-dependent insulin secretion
  • Reduce glucagon when glucose is elevated
  • Slow gastric emptying
  • Reduce appetite and body weight
  • Improve insulin sensitivity indirectly via fat loss

The result for many patients:

  • Lower fasting glucose
  • Reduced post-meal spikes
  • Significant A1C reduction
  • Substantial weight loss

Some patients go from poorly controlled diabetes (A1C 9-10+ or higher) to near-normal levels (5-6 range) over time.

--------------------------------------------------
2. HOW MUCH CAN A1C IMPROVE?
--------------------------------------------------

From both clinical trials and community reports:

Semaglutide-type meds
  • Often reduce A1C by ~1–1.5% (sometimes more)
  • Strong weight loss effect

Tirzepatide-type meds
  • A1C reductions frequently in the ~2% range
  • Higher percentage of participants reaching A1C < 5.7% in trials compared to earlier GLP-1s
  • Major weight loss

Retatrutide-type agents (still under investigation)
  • Promising early data for weight loss
  • Strong glucose-lowering signals
  • Not yet fully established whether superior to tirzepatide for glycemic control

Important: Trial populations differ. You cannot compare numbers across studies like they were done head-to-head unless they actually were.

Also: real-world results vary. Some people respond dramatically. Others plateau.

--------------------------------------------------
3. "MY A1C WAS AMAZING… NOW IT'S CREEPING UP"
--------------------------------------------------

This is more common than people expect.

Possible reasons:

  • Beta cell decline continues (T2D is progressive)
  • Body adapts to medication over time
  • Weight stabilizes or slight regain
  • Diet becomes less strict
  • Dose already at max

What can be considered (with a clinician):

  • Re-evaluating diet (hidden carbs add up)
  • Increasing protein and fiber
  • Ensuring dose titrated appropriately
  • Adding metformin if not already on it
  • Adding an SGLT2 inhibitor
  • Evaluating whether a medication switch makes sense

Stacking incretin-based injectables is not standard medical practice and should not be done casually.

--------------------------------------------------
4. DIET STILL MATTERS (YES, REALLY)
--------------------------------------------------

The biggest long-term success stories are not just "I took the shot."

The pattern I see repeatedly in people who go from severe obesity and uncontrolled diabetes to remission-level A1C:

  • High protein focus
  • More vegetables and whole foods
  • Minimal added sugars
  • Lower overall carbohydrate load
  • Consistent sleep schedule
  • Regular walking or strength training

The medication reduces hunger and cravings. It opens the door. But walking through that door is behavior.

People who treat the medication as a metabolic assist rather than a miracle tend to maintain results longer.

--------------------------------------------------
5. WHAT ABOUT PREDIABETES?
--------------------------------------------------

This is controversial.

No GLP-1 medication is officially approved specifically for "prediabetes." Physicians may prescribe off-label if risk is high (obesity, PCOS, strong family history, rising A1C, metabolic syndrome).

Insurance frequently denies coverage in prediabetes without a formal T2D diagnosis.

Before pursuing expensive options, consider:

  • Structured nutrition changes
  • Resistance training (improves insulin sensitivity significantly)
  • Sleep optimization
  • Metformin (low-cost, well studied in prediabetes)

GLP-1 medications can be powerful, but they are not the only intervention.

--------------------------------------------------
6. COST AND COVERAGE REALITY
--------------------------------------------------

Let's be honest.

Many people are denied coverage.

Common scenarios:

  • Approved for T2D but not for weight loss
  • Coverage changed mid-year
  • High copays after manufacturer assistance expired
  • Appeals denied

Important safety note:

Obtaining medications without proper medical supervision carries real risks:

  • Incorrect dosing
  • Unknown product quality
  • Contamination risk
  • Lack of monitoring (A1C, kidney function, etc.)

For diabetes, regular labs and medical oversight are not optional.

--------------------------------------------------
7. DOSING BASICS (GENERAL INFORMATION)
--------------------------------------------------

Always follow your prescriber.

Typical patterns:

GLP-1 or dual agonists
  • Start low
  • Increase every 4 weeks (sometimes longer)
  • Goal is balance between glucose control and tolerability

Common side effects:
  • Nausea
  • Early satiety
  • Constipation or diarrhea
  • Fatigue early on

Tips from experience:

  • Smaller meals
  • Avoid high-fat, high-sugar meals early in titration
  • Hydrate aggressively
  • Prioritize protein

--------------------------------------------------
8. CAN YOU HIT "REMISSION"?
--------------------------------------------------

Some individuals achieve:

  • A1C < 5.7%
  • Normal fasting glucose
  • No additional diabetes meds

This is often called "remission," especially when sustained.

But remember:

Type 2 diabetes is a chronic condition. If weight is regained or medication stopped, hyperglycemia often returns.

Think in terms of control, not cure.

--------------------------------------------------
9. WHAT ABOUT SUPPLEMENTS LIKE GLYCINE?
--------------------------------------------------

You may see discussion about glycine as a sweetener or supplement.

Glycine is a nonessential amino acid. It does not meaningfully raise blood glucose when consumed orally in typical amounts.

It may be used as:

  • A low-calorie sweetener alternative
  • A general supplement

But:

  • It is not a replacement for diabetes medication
  • It is not a proven primary glucose-lowering therapy

If using it as a sweetener alternative, monitor your own glucose response.

--------------------------------------------------
10. MENTAL SHIFT: IDENTITY CHANGE
--------------------------------------------------

One of the most powerful themes I have seen:

People who succeed long term do not just lose weight.

They change identity.

Examples of behavior shifts:

  • From late-night eating to consistent sleep
  • From sedentary to walking daily
  • From high-sugar to high-protein
  • From shame to structured discipline

The medication reduces biological resistance.
The habits build the new baseline.

--------------------------------------------------
11. IF YOU ARE JUST STARTING
--------------------------------------------------

Here is a practical checklist:

  • Get baseline labs: A1C, fasting glucose, CMP, lipids
  • Discuss full medication history
  • Start at lowest recommended dose
  • Track weight weekly (not daily obsessively)
  • Track A1C every 3 months
  • Lift weights 2-3x/week if possible
  • Walk daily
  • Eat 0.7–1g protein per lb goal body weight (if appropriate)

--------------------------------------------------
12. FINAL THOUGHTS
--------------------------------------------------

GLP-1, dual, and triple agonists are among the most powerful metabolic medications we have ever had for T2D.

But:

They are tools.
Not magic.

The best outcomes combine:

  • Medication
  • Dietary structure
  • Muscle-preserving exercise
  • Sleep consistency
  • Regular lab monitoring

If your A1C has dropped from dangerous levels to normal range, that is not luck.

That is intervention plus behavior.

If you are struggling, ask questions. If you are succeeding, share what worked.

We are all trying to stay metabolically healthy in a very unhealthy food environment.

You've got this.
 
Thank you for writing this. I am newly diagnosed T2D and overwhelmed.

Fiber_Lean said:
Think in terms of control, not cure.

This part hit me. My doctor mentioned remission and I got excited, but I guess I need to think long term. If someone gets to A1C 5.5 on tirzepatide, do they usually stay on it forever?
 
Great overview.

To answer the remission question: in most cases, if glycemic control is medication-dependent, stopping the medication results in rising glucose over time. Some patients who lose substantial weight and maintain it can reduce dose, but many require ongoing therapy.

Type 2 diabetes is progressive. Early aggressive control is beneficial, but it does not mean the disease disappears.
 
I love that you emphasized sleep. I ignored that for months.

Fiber_Lean said:
The medication reduces hunger and cravings. It opens the door.

This has been my experience exactly. When I started going to bed at a consistent time, my late night snacking basically stopped. The shot made it easier but the routine sealed it.
 
Very balanced post.

I would add that head-to-head comparisons between dual and triple agonists are limited. Different trial populations, durations, and background therapies make cross-trial interpretation tricky.

Also, for those with cardiovascular risk, some of the established GLP-1 agents have long-term outcome data showing CV benefit. That matters in diabetes management, not just A1C reduction.
 
This might be a dumb question but when you say prioritize protein, how much are we talking? I am 220 lbs and trying to lose. I feel full fast on my injections and sometimes barely hit 60g a day.

Fiber_Lean said:
Lift weights 2-3x/week if possible

I have never lifted before so that part scares me.
 
Jumping in on the protein question.

For patients on GLP-1 or dual agonists, preserving lean mass is critical. Rapid weight loss without adequate protein and resistance training increases muscle loss.

While exact targets vary, many clinicians suggest roughly 0.8–1.0 grams per pound of goal body weight, adjusted for kidney function and individual tolerance. If appetite is low, protein-dense foods first is a practical strategy.

And lifting can start very simply: bodyweight squats, resistance bands, light dumbbells.
 
I just want to say I am one of those people who went from A1C 9+ to low 5s with meds plus cleaning up my diet. Down over 100 lbs.

The shot helped a ton but cutting added sugar and walking daily changed everything. Stadium seats are way more comfortable now lol.

This stuff works if you work it.
 
Appreciate the part about supplements.

I tried glycine as a sweetener and my CGM barely moved, which was nice. But yeah, it is not a diabetes treatment.

The real game changer for me was consistency. Med, meals, movement, repeat.
 
That phrase gets thrown around so much it sounds like marketing now instead of something real. Everyone's different and saying journey makes it feel generic. I like when folks talk about actual changes or goals - feels more honest and personal.
 
So are they blended or separate? If blended try a rapid titration—I did 100 each my first two days to make sure, then 200 each for the other three days, eventually landed on 350 each. Fair warning: might get a niacin-flush warmth in the face. I kinda like it. Heart rate bumps a bit too but goes away in 30-45 minutes.
 
Just started, 2 doses in at 0.3mg. Can't tell if it's working yet. Started with semaglutide and it went well. Thought about stacking low-dose semaglutide with tirz but decided to try a compounded option instead. I'd read it's an effective pairing. We'll see.
 
I don't think we're on the same page. From what you've said, you already dosed 600mcg on your last injection plus whatever else you did before. Do you have a record of when you took each dose and how many units? Please give units, not mcg.
 
you've got 3 doses left on the kwikpen so you can dial down fractions. agreed with my GP to do 1.25mg for first 2 weeks—no sides but no appetite suppression either, switched to full 2.5 on dose 3. i'd delay the next shot 2-3 days to let sides calm, then try half dose max.
 
Back
Top